Gilead Sciences, Inc. (GILD)
NASDAQ: GILD · Real-Time Price · USD
142.71
+1.17 (0.83%)
Apr 9, 2026, 1:51 PM EDT - Market open
Gilead Sciences Stock Forecast
Stock Price Forecast
The 18 analysts that cover Gilead Sciences stock have a consensus rating of "Strong Buy" and an average price target of $146.5, which forecasts a 2.66% increase in the stock price over the next year. The lowest target is $112 and the highest is $180.
Price Target: $146.5 (+2.66%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 10, 2026.
Analyst Ratings
The average analyst rating for Gilead Sciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 8 | 7 | 7 | 7 |
| Buy | 10 | 9 | 9 | 8 | 8 | 8 |
| Hold | 5 | 4 | 4 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 22 | 20 | 21 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy Initiates $180 | Strong Buy | Initiates | $180 | +26.13% | Mar 10, 2026 |
| Needham | Needham | Strong Buy Reiterates $170 | Strong Buy | Reiterates | $170 | +19.12% | Feb 23, 2026 |
| Barclays | Barclays | Hold Initiates $155 | Hold | Initiates | $155 | +8.61% | Feb 20, 2026 |
| RBC Capital | RBC Capital | Hold Maintains $103 → $118 | Hold | Maintains | $103 → $118 | -17.31% | Feb 11, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $145 → $152 | Strong Buy | Maintains | $145 → $152 | +6.51% | Feb 11, 2026 |
Financial Forecast
Revenue This Year
30.81B
from 29.44B
Increased by 4.65%
Revenue Next Year
32.65B
from 30.81B
Increased by 5.96%
EPS This Year
8.84
from 6.78
Increased by 30.40%
EPS Next Year
9.83
from 8.84
Increased by 11.20%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 32.4B | 35.5B | |||
| Avg | 30.8B | 32.7B | |||
| Low | 29.1B | 30.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 10.0% | 15.3% | |||
| Avg | 4.7% | 6.0% | |||
| Low | -1.0% | -2.2% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.35 | 11.19 | |||
| Avg | 8.84 | 9.83 | |||
| Low | 8.12 | 8.08 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 37.8% | 26.6% | |||
| Avg | 30.4% | 11.2% | |||
| Low | 19.8% | -8.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.